Regeneron Pharmaceuticals, Inc. (REGN)
852.29
+28.47
(+3.46%)
USD |
NASDAQ |
Sep 02, 16:00
850.01
-2.28
(-0.27%)
After-Hours: 20:00
Regeneron Pharmaceuticals Cash and Short Term Investments (Quarterly) : 8.005B for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.005B |
| March 31, 2026 | 8.762B |
| December 31, 2025 | 8.611B |
| September 30, 2025 | 8.450B |
| June 30, 2025 | 7.489B |
| March 31, 2025 | 8.349B |
| December 31, 2024 | 9.012B |
| September 30, 2024 | 9.796B |
| June 30, 2024 | 9.816B |
| March 31, 2024 | 10.52B |
| December 31, 2023 | 10.84B |
| September 30, 2023 | 9.914B |
| June 30, 2023 | 8.933B |
| March 31, 2023 | 8.960B |
| December 31, 2022 | 7.742B |
| September 30, 2022 | 7.022B |
| June 30, 2022 | 7.566B |
| March 31, 2022 | 7.051B |
| December 31, 2021 | 5.695B |
| September 30, 2021 | 5.788B |
| June 30, 2021 | 3.911B |
| March 31, 2021 | 3.504B |
| December 31, 2020 | 3.587B |
| September 30, 2020 | 3.026B |
| June 30, 2020 | 3.144B |
| Date | Value |
|---|---|
| March 31, 2020 | 4.003B |
| December 31, 2019 | 3.214B |
| September 30, 2019 | 2.878B |
| June 30, 2019 | 2.670B |
| March 31, 2019 | 3.232B |
| December 31, 2018 | 2.810B |
| September 30, 2018 | 2.192B |
| June 30, 2018 | 1.684B |
| March 31, 2018 | 1.625B |
| December 31, 2017 | 1.410B |
| September 30, 2017 | 1.379B |
| June 30, 2017 | 1.268B |
| March 31, 2017 | 1.307B |
| December 31, 2016 | 1.039B |
| September 30, 2016 | 1.408B |
| June 30, 2016 | 1.045B |
| March 31, 2016 | 849.18M |
| December 31, 2015 | 1.045B |
| September 30, 2015 | 895.64M |
| June 30, 2015 | 604.25M |
| March 31, 2015 | 742.16M |
| December 31, 2014 | 900.48M |
| September 30, 2014 | 1.042B |
| June 30, 2014 | 816.91M |
| March 31, 2014 | 648.13M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| AbbVie, Inc. | 6.569B |
| Gilead Sciences, Inc. | 4.882B |
| Amgen, Inc. | 13.99B |
| Biogen, Inc. | 1.285B |